Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00034307
What this trial is testing

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
ICOS-Texas Biotechnology 180
Not applicableStudy completedNCT03364244
What this trial is testing

Revatio Special Investigation for Long-term Use in Pediatric Patients

Who this might be right for
Pulmonary Arterial Hypertension
Viatris Pharmaceuticals Japan Inc 1,023
Not applicableStudy completedNCT01181284
What this trial is testing

Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)

Who this might be right for
Pulmonary Arterial Hypertension
Mayo Clinic 24
Not applicableWithdrawnNCT02309463
What this trial is testing

Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion
Not applicableStudy completedNCT04744584
What this trial is testing

Medication Reconciliation in Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Hypertension Chronic ThromboembolicPulmonary Arterial Hypertension
Assistance Publique - Hôpitaux de Paris 129
Post-approval studies (Phase 4)Not Yet RecruitingNCT07600723
What this trial is testing

Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06683040
What this trial is testing

Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 260
Not applicableStudy completedNCT02428985
What this trial is testing

Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Bayer 882
Not applicableStudy completedNCT00257413
What this trial is testing

Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Zhejiang University
Not applicableStudy completedNCT03365479
What this trial is testing

Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Arterial Hypertension
University of Giessen 30
Early research (Phase 1)Study completedNCT00469027
What this trial is testing

Pulmonary Hypertension: Assessment of Cell Therapy

Who this might be right for
Hypertension, Pulmonary
Northern Therapeutics 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06176118
What this trial is testing

Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University Medical Center 12
Not applicableStudy completedNCT04104490
What this trial is testing

Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Florida 79
Early research (Phase 1)Ended earlyNCT01244620
What this trial is testing

A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 16
Post-approval studies (Phase 4)UnknownNCT03236818
What this trial is testing

Goal Oriented Strategy to Preserve Ejection Fraction Trial

Who this might be right for
Pulmonary Arterial Hypertension
Amsterdam UMC, location VUmc 30
Not applicableStudy completedNCT02845518
What this trial is testing

Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)

Who this might be right for
Pulmonary Arterial Hypertension
Central Hospital, Nancy, France 169
Not applicableNot Yet RecruitingNCT07804589
What this trial is testing

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals

Who this might be right for
High AltitudeHealthyHealthy Adult+4 more
Silvia Ulrich Somaini 14
Not applicableNot Yet RecruitingNCT06987097
What this trial is testing

Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Nanjing First Hospital, Nanjing Medical University 410
Post-approval studies (Phase 4)Study completedNCT01330108
What this trial is testing

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Alabama at Birmingham 32
Not applicableStudy completedNCT03105934
What this trial is testing

Repeatability of OCT and IV-US in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Hospital Universitari Vall d'Hebron Research Institute 20
Next Page